Canonical page: https://www.hermindandwellness.com/learn/auvelity-depression-what-patients-should-know/ [Home](https://www.hermindandwellness.com/)[Education guides](https://www.hermindandwellness.com/learn)[Depression and low motivation](https://www.hermindandwellness.com/learn/topics/depression) Auvelity and Faster Depression Relief: Read Beyond the Headline Patient guide · Depression and low motivation # Auvelity and Faster Depression Relief: Read Beyond the Headline What Auvelity’s depression studies and 2026 news mean for patients, including realistic timelines, medication interactions, side effects, and follow-up. [](https://www.hermindandwellness.com/elizabeth-ghadimi) Clinically reviewed by [Elizabeth Ghadimi, PMHNP-BC](https://www.hermindandwellness.com/elizabeth-ghadimi) Psychiatric-Mental Health Nurse Practitioner Clinical review confirmed October 30, 2026 Illustrative stock photograph · Artem Podrez / Pexels [Medication questions](https://www.hermindandwellness.com/learn/tags/medication-questions) In this guide[A practical starting point](https://www.hermindandwellness.com/#1)[What did “one week” mean in the study?](https://www.hermindandwellness.com/#2)[Why is it in the news again in 2026?](https://www.hermindandwellness.com/#3)[The medication list matters](https://www.hermindandwellness.com/#4)[Give follow-up something concrete to measure](https://www.hermindandwellness.com/#5)[Sources](https://www.hermindandwellness.com/#6) ## A practical starting point When you are depressed, “give it more time” can feel like being put on hold by your own brain. Research on earlier improvement matters. So does understanding what researchers mean by “earlier.” Auvelity combines dextromethorphan and bupropion. It was approved for major depressive disorder in adults in 2022.[1] You may recognize dextromethorphan from cough products, but that does not make a cough medicine a substitute for this prescription treatment. Do not attempt to recreate it yourself. ## What did “one week” mean in the study? The published GEMINI trial reported improvement compared with placebo: “starting 1 week after treatment initiation”[2, Conclusions] That was an average difference on a depression rating scale. It was not a promise that every participant felt well within seven days. In this six-week study of 327 adults, 39.5% receiving dextromethorphan-bupropion reached the study’s remission threshold, compared with 17.3% receiving placebo. Remission meant a low symptom score at that assessment, rather than proof that depression could never return.[2] The study compared the medication with placebo. It does not establish that Auvelity is better than every commonly prescribed antidepressant, and its results do not apply automatically to everyone with depression.[2] ## Why is it in the news again in 2026? On April 30, 2026, the FDA approved an additional use: agitation associated with dementia due to Alzheimer’s disease in adults.[1] That is a separate condition. It does not make Auvelity a general treatment for irritability, stress, or ordinary frustration. If you see a new headline, ask which diagnosis the news actually concerns. The same brand name can appear in very different treatment conversations. ## The medication list matters Before treatment, the prescriber should review blood pressure, bipolar history, and other products containing bupropion or dextromethorphan. Important risks include seizures, increased blood pressure, activation of mania, and serotonin syndrome with certain combinations. A seizure disorder or current or past anorexia or bulimia can rule it out.[3] Common side effects include dizziness, headache, diarrhea, sleepiness, dry mouth, sweating, and sexual dysfunction. Antidepressant labeling warns about increased suicidal thoughts and behaviors in younger patients and calls for monitoring.[3] Tell your clinician about cough medicines, supplements, and alcohol use—not just your psychiatric prescriptions. ## Give follow-up something concrete to measure Before starting any new depression treatment, write down two or three changes that would matter to you. Examples might be getting out of bed with less struggle, enjoying dinner with your family, or completing a workday with less distress. Then ask: When should we look for change? What should I report sooner? If there is some benefit but troublesome dizziness, what are our options? What will this cost after any introductory discount ends? “Faster” is useful information. Your ability to function, tolerate treatment, and afford continued care still belongs at the center of the decision. Want help understanding your medication options? Explore care options with Her Mind & Wellness (https://www.hermindandwellness.com/). ## Sources 1. FDA. *FDA Approves First Non-Antipsychotic Drug to Treat Agitation Associated with Dementia*. April 30, 2026. FDA announcement (https://www.fda.gov/news-events/press-announcements/fda-approves-first-non-antipsychotic-drug-treat-agitation-associated-dementia). 2. Iosifescu DV, et al. Efficacy and Safety of AXS-05 (Dextromethorphan-Bupropion) in Patients With Major Depressive Disorder: A Phase 3 Randomized Clinical Trial (GEMINI). *Journal of Clinical Psychiatry*. 2022;83(4):21m14345. DOI: 10.4088/JCP.21m14345. Original research abstract (https://pubmed.ncbi.nlm.nih.gov/35649167/). 3. Axsome Therapeutics. *Auvelity FDA prescribing information*. April 2026; sections 1, 2.1, 4–7, and 14.1. FDA label (https://www.accessdata.fda.gov/drugsatfda_docs/label/2026/215430s009s018lbl.pdf). This article provides general education and does not replace an individualized evaluation. Do not start, stop, combine, or change psychiatric medications without guidance from your prescriber. Seek immediate medical help for a severe reaction or an immediate safety concern. This material is educational and does not diagnose or replace personal medical advice. Do not start, stop or change medication based on this page. For suicidal thoughts or a mental health crisis in the United States, call or text 988. If you are in immediate danger or having a medical emergency, call 911. Website appointment requests are not an emergency service. ## Sources - [NIMH: Mental Health Medications](https://www.nimh.nih.gov/health/topics/mental-health-medications) - [FDA: Drug Safety and Availability](https://www.fda.gov/drugs/drug-safety-and-availability) ## Considering an appointment? Explore [in-person adult psychiatric evaluations in El Paso](https://www.hermindandwellness.com/elpaso) or [adult psychiatric telehealth throughout Texas](https://www.hermindandwellness.com/care). Learn more about [Elizabeth Ghadimi’s credentials](https://www.hermindandwellness.com/elizabeth-ghadimi). Insurance booking is handled through Headway; self-pay requests are confirmed by the practice. ## Related guides - [A New Bipolar Medication in 2026: What Bysanti Is Actually For](https://www.hermindandwellness.com/learn/bysanti-bipolar-mania-new-medication-2026) - [ADHD or anxiety? Why Adderall can make you feel worse](https://www.hermindandwellness.com/learn/adhd-or-anxiety-adderall-panic-attacks) - [Mood swings, irritability, and sleep changes: what an evaluation can clarify](https://www.hermindandwellness.com/learn/mood-swings-irritability-sleep-psychiatric-evaluation)